Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

VU0155069

PLD inhibitor
 
BML-ST370-0005 5 mg 92.00 USD
 
BML-ST370-0025 25 mg 330.00 USD
Do you need bulk/larger quantities?
 
Potent and specific inhibitor of phospholipase D1 (PLD1) in cellular (PLD1 IC50 = 11nM Calu-1 cells; PLD2 IC50 = 1800nM HEK293-gfpPLD2 cells) and in vitro (hPLD1 IC50 = 46nM; hPLD2 IC50 = 933nM) assays. Significantly decreases invasive migration in breast cancer cell lines (MDA-231, 4T1 and PMT).

Product Specification

Alternative Name:N-[(2S)-1-[4-(5-Chloro-2-oxo-3H-benzimidazol-1-yl)-piperidin-1-yl]-propan-2-yl]naphthalene-2-carboxamide
 
Formula:C26H27ClN4O2
 
MW:463.0
 
CAS:1130067-06-9
 
Purity:≥98% (TLC)
 
Appearance:Pale-yellow solid.
 
Solubility:Soluble in DMSO (>25mg/ml) or 100% ethanol (>25mg/ml).
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Use/Stability:Store solutions at -20°C for up to 3 months.
 
BML-ST370 new
Please mouse over
BML-ST370 new

Product Literature References

Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness: S.A. Scott, et al.; Nat. Chem. Biol. 5, 108 (2009), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
PLD
By biological activity:
PLD Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,